标题
Targeting PVR (CD155) and its receptors in anti-tumor therapy
作者
关键词
-
出版物
Cellular & Molecular Immunology
Volume 16, Issue 1, Pages 51-63
出版商
Springer Nature
发表日期
2018-10-01
DOI
10.1038/s41423-018-0168-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor
- (2018) Alexander D. Barrow et al. CELL
- Recent progress in therapeutic antibodies for cancer immunotherapy
- (2018) Anthony Lee et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Engineering T cells for adoptive therapy: outsmarting the tumor
- (2018) Andre Kunert et al. CURRENT OPINION IN IMMUNOLOGY
- Antibody-drug conjugates: Promising and efficient tools for targeted cancer therapy
- (2018) Hadi Nasiri et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The expanding constellation of immune checkpoints: a DNAMic control by CD155
- (2018) Vincenzo Bronte JOURNAL OF CLINICAL INVESTIGATION
- CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms
- (2018) Xian-Yang Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity
- (2018) Karen O. Dixon et al. JOURNAL OF IMMUNOLOGY
- Poliovirus Receptor (CD155) Expression in Pediatric Brain Tumors Mediates Oncolysis of Medulloblastoma and Pleomorphic Xanthoastrocytoma
- (2018) Eric M Thompson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
- (2018) Yanyu Pang et al. Molecular Cancer
- Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
- (2018) Qing Zhang et al. NATURE IMMUNOLOGY
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option
- (2018) Hauke Stamm et al. ONCOGENE
- Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
- (2018) Paula Salmikangas et al. PHARMACEUTICAL RESEARCH
- CD96 expression determines the inflammatory potential of IL-9–producing Th9 cells
- (2018) Katarina Stanko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies
- (2018) Sandra Rosskopf et al. Oncotarget
- Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors
- (2018) Paris Kosti et al. Frontiers in Immunology
- Coming of Age: CD96 Emerges as Modulator of Immune Responses
- (2018) Hristo Georgiev et al. Frontiers in Immunology
- CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity
- (2018) Amelia Roman Aguilera et al. OncoImmunology
- Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis
- (2018) Heidi Harjunpää et al. OncoImmunology
- Interplay between tight junctions & adherens junctions
- (2017) Hannah K. Campbell et al. EXPERIMENTAL CELL RESEARCH
- TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy
- (2017) William C. Dougall et al. IMMUNOLOGICAL REVIEWS
- CD155 knockdown promotes apoptosis via AKT/Bcl-2/Bax in colon cancer cells
- (2017) Qianqian Zheng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Emerging targets in cancer immunotherapy
- (2017) Samantha Burugu et al. SEMINARS IN CANCER BIOLOGY
- Poliovirus Receptor: More than a simple viral receptor
- (2017) Jonathan R. Bowers et al. VIRUS RESEARCH
- CD155 expression and its correlation with clinicopathologic characteristics, angiogenesis, and prognosis in human cholangiocarcinoma
- (2017) Da-Wei Huang et al. OncoTargets and Therapy
- Targeting Nectin-4 in Bladder Cancer
- (2017) Cancer Discovery
- Current progress in innovative engineered antibodies
- (2017) William R. Strohl Protein & Cell
- Cd226−/− natural killer cells fail to establish stable contacts with cancer cells and show impaired control of tumor metastasis in vivo
- (2017) Ji Sung Kim et al. OncoImmunology
- Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors
- (2017) Sheila López-Cobo et al. OncoImmunology
- Cancer immunotherapy: Wound-bound checkpoint blockade
- (2017) Morteza Mahmoudi et al. Nature Biomedical Engineering
- Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models
- (2016) P. M. Challita-Eid et al. CANCER RESEARCH
- Oncolytic virus therapy: A new era of cancer treatment at dawn
- (2016) Hiroshi Fukuhara et al. CANCER SCIENCE
- Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy
- (2016) S. J. Blake et al. CLINICAL CANCER RESEARCH
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
- (2016) Ana C. Anderson et al. IMMUNITY
- Immune checkpoint inhibitors side effects and management
- (2016) Hampig Raphael Kourie et al. Immunotherapy
- How Chimeric Antigen Receptor Design Affects Adoptive T Cell Therapy
- (2016) Albert T. Gacerez et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Inflammatory monocytes and NK cells play a crucial role in DNAM-1–dependent control of cytomegalovirus infection
- (2016) Tihana Lenac Rovis et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell–Treated Mice
- (2016) Marie-Louise Sentman et al. JOURNAL OF IMMUNOLOGY
- Melanoma Cells Control Antimelanoma CTL Responses via Interaction between TIGIT and CD155 in the Effector Phase
- (2016) Takashi Inozume et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Sensitivity of dendritic cells to NK-mediated lysis depends on the inflammatory environment and is modulated by CD54/CD226-driven interactions
- (2016) Laura E. Smith et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
- (2016) Hanren Dai et al. JNCI-Journal of the National Cancer Institute
- Cytotoxic potential of IL-15-activated cytokine-induced killer cells against human neuroblastoma cells
- (2016) Claudia Cappel et al. PEDIATRIC BLOOD & CANCER
- Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy
- (2016) S. J. Blake et al. Cancer Discovery
- Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
- (2016) Hanren Dai et al. JNCI-Journal of the National Cancer Institute
- Increased Soluble CD155 in the Serum of Cancer Patients
- (2016) Akiko Iguchi-Manaka et al. PLoS One
- TRUCKs: the fourth generation of CARs
- (2015) Markus Chmielewski et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients
- (2015) Joe-Marc Chauvin et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- TIGIT predominantly regulates the immune response via regulatory T cells
- (2015) Sema Kurtulus et al. JOURNAL OF CLINICAL INVESTIGATION
- CD155 (PVR/Necl5) Mediates a Costimulatory Signal in CD4+T Cells and Regulates Allergic Inflammation
- (2015) Yumi Yamashita-Kanemaru et al. JOURNAL OF IMMUNOLOGY
- Oncolytic viruses: a new class of immunotherapy drugs
- (2015) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
- (2015) W. Deng et al. SCIENCE
- Proteolysis of MDA5 and IPS-1 is not required for inhibition of the type I IFN response by poliovirus
- (2015) Swathi Kotla et al. Virology Journal
- DNAM-1 Expression Marks an Alternative Program of NK Cell Maturation
- (2015) Ludovic Martinet et al. Cell Reports
- Cytotoxic and immunogenic mechanisms of recombinant oncolytic poliovirus
- (2015) Michael C Brown et al. Current Opinion in Virology
- Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma
- (2015) Valentina Bevelacqua et al. Oncotarget
- Oncolytic polio virotherapy of cancer
- (2014) Michael C. Brown et al. CANCER
- The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
- (2014) Robert J. Johnston et al. CANCER CELL
- TIGIT and CD226: Tipping the Balance between Costimulatory and Coinhibitory Molecules to Augment the Cancer Immunotherapy Toolkit
- (2014) Kristen E. Pauken et al. CANCER CELL
- DNAM-1-based chimeric antigen receptors enhance T cell effector function and exhibit in vivo efficacy against melanoma
- (2014) Ming-Ru Wu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses
- (2014) Nicole Joller et al. IMMUNITY
- The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
- (2014) Christopher J Chan et al. NATURE IMMUNOLOGY
- Clinical application of adoptive T cell therapy in solid tumors
- (2014) Zong-You Chen MEDICAL SCIENCE MONITOR
- Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma
- (2014) Alessandra Soriani et al. OncoImmunology
- Poliovirus Receptor (CD155) Regulates a Step in Transendothelial Migration between PECAM and CD99
- (2013) David P. Sullivan et al. AMERICAN JOURNAL OF PATHOLOGY
- Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR
- (2013) Noa Stanietsky et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins
- (2013) Lucas Ferrari de Andrade et al. IMMUNOLOGY AND CELL BIOLOGY
- At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy
- (2013) Margaret K. Callahan et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers
- (2013) Tsutomu Oshima et al. Molecular Cancer
- Toll-Like Receptor Ligands Induce Expression of the Costimulatory Molecule CD155 on Antigen-Presenting Cells
- (2013) Neha Kamran et al. PLoS One
- Prognostic significance of CD155 mRNA expression in soft tissue sarcomas
- (2013) SATORU ATSUMI et al. Oncology Letters
- Necl-5/Poliovirus Receptor Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis
- (2012) Mitsuo Kinugasa et al. CIRCULATION RESEARCH
- The role of Necl-5 in the invasive activity of lung adenocarcinoma
- (2012) Shinya Tane et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Crystal Structure of Cell Adhesion Molecule Nectin-2/CD112 and Its Binding to Immune Receptor DNAM-1/CD226
- (2012) J. Liu et al. JOURNAL OF IMMUNOLOGY
- Receptors for Hyaluronic Acid and Poliovirus: A Combinatorial Role in Glioma Invasion?
- (2012) Zaynah Maherally et al. PLoS One
- Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell-cell adhesion and signaling mechanism that requires cis-trans receptor clustering
- (2012) K. F. Stengel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD155 on Human Vascular Endothelial Cells Attenuates the Acquisition of Effector Functions in CD8 T Cells
- (2011) Nichole K. Escalante et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity
- (2011) A. Pievani et al. BLOOD
- Oncolytic poliovirus against malignant glioma
- (2011) Christian Goetz et al. Future Virology
- Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients
- (2011) Beatriz Sanchez-Correa et al. IMMUNOLOGY AND CELL BIOLOGY
- Intranodal Interaction with Dendritic Cells Dynamically Regulates Surface Expression of the Co-stimulatory Receptor CD226 Protein on Murine T Cells
- (2011) Sebastian Seth et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- (2011) Emilie Mamessier et al. JOURNAL OF CLINICAL INVESTIGATION
- Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
- (2011) N. Joller et al. JOURNAL OF IMMUNOLOGY
- The Toll-Like Receptor 3-Mediated Antiviral Response Is Important for Protection against Poliovirus Infection in Poliovirus Receptor Transgenic Mice
- (2011) Y. Abe et al. JOURNAL OF VIROLOGY
- Overexpression of Necl-5 correlates with unfavorable prognosis in patients with lung adenocarcinoma
- (2010) Reiko Nakai et al. CANCER SCIENCE
- Paired NK cell receptors controlling NK cytotoxicity
- (2010) Noa Stanietsky et al. FEBS LETTERS
- Inhibition of Necl-5 (CD155/PVR) reduces glioblastoma dispersal and decreases MMP-2 expression and activity
- (2010) Brian M. Enloe et al. JOURNAL OF NEURO-ONCOLOGY
- Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome
- (2010) M Carlsten et al. LEUKEMIA
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- Tissue Type-Specific Expression of the dsRNA-Binding Protein 76 and Genome-Wide Elucidation of Its Target mRNAs
- (2010) Valentina Neplioueva et al. PLoS One
- Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells
- (2009) M. Carlsten et al. JOURNAL OF IMMUNOLOGY
- DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases
- (2009) C. J. Chan et al. JOURNAL OF IMMUNOLOGY
- NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties
- (2009) R. Castriconi et al. JOURNAL OF IMMUNOLOGY
- Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells
- (2009) Sebastian Seth et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Proteinase 2Apro Is Essential for Enterovirus Replication in Type I Interferon-Treated Cells
- (2009) J. M. Morrison et al. JOURNAL OF VIROLOGY
- The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
- (2009) N. Stanietsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
- (2008) A. Soriani et al. BLOOD
- CD96 Interaction with CD155 via Its First Ig-like Domain Is Modulated by Alternative Splicing or Mutations in Distal Ig-like Domains
- (2008) Dorothee Meyer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Accelerated tumor growth in mice deficient in DNAM-1 receptor
- (2008) Akiko Iguchi-Manaka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors
- (2008) Susan Gilfillan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Recombinant Oncolytic Poliovirus Eliminates Glioma In Vivo Without Genetic Adaptation to a Pathogenic Phenotype
- (2008) Elena Y Dobrikova et al. MOLECULAR THERAPY
- The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
- (2008) Xin Yu et al. NATURE IMMUNOLOGY
- Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation
- (2008) Yoshimi Takai et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started